Publications dans lesquelles il/elle collabore avec Celia Pilar Martínez Jiménez (7)

2007

  1. Transcriptional regulation and expression of CYP3A4 in hepatocytes

    Current Drug Metabolism, Vol. 8, Núm. 2, pp. 185-194

2006

  1. Hepatocyte cell lines: Their use, scope and limitations in drug metabolism studies

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Núm. 2, pp. 183-212

  2. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4α requires coactivators peroxisomal proliferator activated receptor-γ coactivator 1α and steroid receptor coactivator 1

    Molecular Pharmacology, Vol. 70, Núm. 5, pp. 1681-1692

  3. Underexpressed coactivators PGC1α and SRC1 impair hepatocyte nuclear factor 4α function and promote dedifferentiation in human hepatoma cells

    Journal of Biological Chemistry, Vol. 281, Núm. 40, pp. 29840-29849

2005

  1. Species-specific mechanisms for cholesterol 7α-hydroxylase (CYP7A1) regulation by drugs and bile acids

    Archives of Biochemistry and Biophysics, Vol. 434, Núm. 1 SPEC. ISS., pp. 75-85

  2. Transcriptional regulation of the human hepatic CYP3A4: Identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein β isoforms (liver activating protein and liver inhibitory protein)

    Molecular Pharmacology, Vol. 67, Núm. 6, pp. 2088-2101

2004

  1. Can hepatoma cell lines be redifferentiated to be used in drug metabolism studies?

    ATLA Alternatives to Laboratory Animals